Here below are the publications (1) participated by Giuseppe Vassalli using the term string doxorubicin (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations).
Any wrong or incomplete data? Any missing, misplaced, unlicensed picture? Please report any abuse, inaccuracy or lack of information to info@ticinoscienza.ch
1) Intravenous administration of cardiac progenitor cell-derived exosomes protects against doxorubicin/trastuzumab-induced cardiac toxicity
Giuseppe Vassalliis currently collaborating with
Istituto Cardiocentro Ticino (ICCT) (Rif. ICCT)
Via Tesserete 48
6900 Lugano
Giuseppe Vassalli
on behalf of
Istituto Cardiocentro Ticino (ICCT) EOC (Rif. ICCT)
is currently participating in the Research Group
Cellular & Molecular Cardiology
as Group Leader [Rif. 55110]
on behalf of
Istituto Cardiocentro Ticino (ICCT) EOC (Rif. ICCT)
is currently participating in the Research Group
Cellular & Molecular Cardiology
as Group Leader [Rif. 55110]